Related Experiment Video
Updated: Mar 11, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
[Lung Cancer]
Kazushi Yoshida1, Takashi Kono
1Division of Genome Biology, National Cancer Center Research Institute.
Abstract:
Personalized lung cancer therapy has progressed by targeting several oncogenic aberrations that drive lung carcinogenesis. Recent advances in gene analysis technologies, including next-generation sequencing that yields large amounts of genomic data, have greatly contributed to this progress. In addition, immune checkpoint blockade therapy has become available in Japan, and extensive searches for biomarkers predictive of therapeutic response have been carried out. "Clinical sequencing" which analyzes aberrations in a set of therapy-related genes in patient cancer specimens, has been actively conducted in Japan and other countries. This will help to establish more efficient and effective precision cancer medicine based on gene information. Herein, we summarize the recent progress in personalized lung cancer therapy research, including clinical sequencing.
Insights
Personalized lung cancer therapy advances through targeting oncogenic aberrations. Clinical sequencing aids in developing more effective precision cancer medicine based on patient gene information.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Personalized lung cancer therapy targets oncogenic aberrations.
- Advances in gene analysis technologies, like next-generation sequencing, drive progress.
- Immune checkpoint blockade therapy is now available, with biomarker research ongoing.
Purpose of the Study:
- To summarize recent progress in personalized lung cancer therapy research.
- To highlight the role of clinical sequencing in precision cancer medicine.
Main Methods:
- Review of recent advancements in personalized lung cancer therapy.
- Focus on gene analysis technologies, including next-generation sequencing.
- Discussion of clinical sequencing for analyzing therapy-related genes.
Main Results:
- Personalized therapy effectively targets oncogenic aberrations.
- Next-generation sequencing provides large-scale genomic data.
- Clinical sequencing is actively conducted globally.
Conclusions:
- Clinical sequencing facilitates efficient and effective precision cancer medicine.
- Gene information is crucial for tailoring lung cancer treatments.
- Continued research in personalized therapy and clinical sequencing is essential.
Related Concept Videos
Other Pulmonary Disorders
lncRNA - Long Non-coding RNAs
Cancer Prevention
Some...
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cancer
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
